Lotus Bio-Technology Development Corp
Lotus Bio-Technology Development Corp. does not have significant operations. The company intends to seek opportunities in the Organic and Bio-technology space. Previously, it is engaged in refining organic materials, and production of natural consumer related products. The company was formerly known as Starflick.com and changed its name to Lotus Bio-Technology Development Corp. in April 2016. Lot… Read more
Lotus Bio-Technology Development Corp (LBTD) - Total Assets
Latest total assets as of March 2021: $55.46K USD
Based on the latest financial reports, Lotus Bio-Technology Development Corp (LBTD) holds total assets worth $55.46K USD as of March 2021.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Lotus Bio-Technology Development Corp - Total Assets Trend (2011–2017)
This chart illustrates how Lotus Bio-Technology Development Corp’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Lotus Bio-Technology Development Corp - Asset Composition Analysis
Current Asset Composition (March 2017)
Lotus Bio-Technology Development Corp's total assets of $55.46K consist of 100.0% current assets and 0.0% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 500.0% |
| Accounts Receivable | $0.00 | 0.0% |
| Inventory | $0.00 | 0.0% |
| Property, Plant & Equipment | $5.46K | 545800.0% |
| Intangible Assets | $0.00 | 0.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2011–2017)
This chart illustrates how Lotus Bio-Technology Development Corp's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Lotus Bio-Technology Development Corp's current assets represent 100.0% of total assets in 2017, an increase from 0.2% in 2011.
- Cash Position: Cash and equivalents constituted 500.0% of total assets in 2017, up from 0.2% in 2011.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, a decrease from 99.0% in 2011.
- Asset Diversification: The largest asset category is property, plant & equipment at 545800.0% of total assets.
Lotus Bio-Technology Development Corp Competitors by Total Assets
Key competitors of Lotus Bio-Technology Development Corp based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Nanjing Red Sun Co Ltd
SHE:000525
|
China | CN¥6.84 Billion |
|
ADAMA Ltd
SHE:000553
|
China | CN¥49.93 Billion |
|
Grand Industrial Holding Co Ltd
SHE:000626
|
China | CN¥8.43 Billion |
|
Qinghai Salt Lake Industry Co.Ltd
SHE:000792
|
China | CN¥50.97 Billion |
|
Sichuan Meifeng Chemical Industry Co Ltd
SHE:000731
|
China | CN¥5.17 Billion |
|
Asia Potash International Investment Guangzhou Co Ltd
SHE:000893
|
China | CN¥19.38 Billion |
|
Hubei Xinyangfeng Fertilizer Co Ltd
SHE:000902
|
China | CN¥19.75 Billion |
|
Sichuan Lutianhua Co Ltd
SHE:000912
|
China | CN¥9.46 Billion |
Lotus Bio-Technology Development Corp - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Lotus Bio-Technology Development Corp generates 0.00x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Lotus Bio-Technology Development Corp is currently not profitable relative to its asset base.
Lotus Bio-Technology Development Corp - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.75 | 0.00 | 0.00 |
| Quick Ratio | 0.75 | 0.00 | 0.00 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $-16.77K | $ -87.78K | $ -66.77K |
Lotus Bio-Technology Development Corp - Advanced Valuation Insights
This section examines the relationship between Lotus Bio-Technology Development Corp's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | - |
| Latest Market Cap to Assets Ratio | 2490790.05 |
| Asset Growth Rate (YoY) | -100.0% |
| Total Assets | $1.00 |
| Market Capitalization | $2.49 Million USD |
Valuation Analysis
Premium Asset Valuation: The market values Lotus Bio-Technology Development Corp's assets at a significant premium ( 2490790.05x), suggesting investors see substantial growth potential or unique competitive advantages.
Significant Asset Reduction: Lotus Bio-Technology Development Corp's assets decreased by 100.0% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Lotus Bio-Technology Development Corp (2011–2017)
The table below shows the annual total assets of Lotus Bio-Technology Development Corp from 2011 to 2017.
| Year | Total Assets | Change |
|---|---|---|
| 2017-03-31 | $1.00 | -99.98% |
| 2016-03-31 | $5.46K | +262.99% |
| 2015-03-31 | $1.50K | +1333.33% |
| 2014-03-31 | $105.00 | -97.42% |
| 2013-03-31 | $4.07K | +890.02% |
| 2012-03-31 | $411.00 | -97.99% |
| 2011-03-31 | $20.48K | -- |